FMS Stock: Price, Earnings History and SEC Filings
Fresenius Medical Care AG (FMS) last traded at $22.47, down 2.85% on the latest session and up 0.4% over the past month. In its most recent reported quarter (Mar 2026) earnings per share were $0.53 against an analyst estimate of $0.59, a miss of 10.2%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
FMS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Mar 2026 | May 5, 2026 | $0.53 | $0.59 | -10.17% |
| Dec 2025 | Feb 24, 2026 | $0.83 | $0.67 | +23.88% |
| Sep 2025 | Nov 4, 2025 | $0.64 | $0.59 | +8.47% |
FMS beat the analyst EPS estimate in 2 of its last 3 reported quarters. Source: Nasdaq.
Latest SEC filings for FMS
Insider filing activity
FMS insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
FMS news
- FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKIOct 23, 2026 · finance.yahoo.com
- Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™Oct 21, 2026 · finance.yahoo.com
- Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026Oct 19, 2026 · finance.yahoo.com
About Fresenius Medical Care AG
Fresenius Medical Care AG (FMS) is a US-listed public company on NYSE. The SEC classifies its business as Services-misc Health & Allied Services NEC.